A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States

Title
A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States
Authors
Keywords
MenACYW-TT, Invasive meningococcal disease, Meningococcal vaccine naïve adolescents, Conjugate vaccine, HPV4, Tdap, Concomitant vaccine
Journal
VACCINE
Volume 38, Issue 19, Pages 3560-3569
Publisher
Elsevier BV
Online
2020-03-22
DOI
10.1016/j.vaccine.2020.03.017

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started